Mathematical Model Helps Predict Cancer Tumor Size (HealthDay)
Posted by admin
the team says its work may help guide development of new tests to improve early detection of cancer. Currently, there's no reliable method of using the results of blood-screening tests to gauge tumefaction size.
The Stanford researchers developed their mathematical model using two common blood biomarkers: prostate specific antigen (PSA), which is often elevated in prostate cancer, and CA125, used as a marker for follow-up therapy in ovarian cancer patients.
Using this model, the researchers found that the minimum tumor sizes predicted by their calculations were close to what was actually seen in clinical practice.
"We're pretty successful that we came up with rather realistic tumor sizes. Although this is a to a high degree basic model, it should give researchers a instrument to employment when deciding if a particular secreted protein would be a good biomarker," radiologist Dr. Amelie Lutz said in a Stanford news release.
"Early cancer detection is a very challenging but of moment goal in spite of the cancer field. This modeling work enables a very deep understanding of the problems that will have to be solved for blood-based cancer biomarkers to exist successful in this striving," study senior author Dr. Sanjiv Sam Gambhir, a professor of radiology, said in the news release.
The study was published in the Aug. 18 issue of the journal PLoS Medicine.
More information
The American Academy of Family Physicians has more about early detection of cancer.
Leave a Reply